The protein that stopped doing chemistry

Vinblastine is on the WHO's list of essential medicines, and it still comes from an old, blunt process: crush enough Madagascar periwinkle (Catharanthus roseus) leaves, and about 500 kilograms of them yields one gram of the drug (UNB Newsroom, July 2026). That ratio isn't a harvesting problem. It's the plant's own chemistry running one step below the edge of falling apart, and a paper out this July finally showed which step and why.

Vinblastine is built from two smaller alkaloids, catharanthine and vindoline, and the shared early stretch of both pathways passes through a molecule called strictosidine aglycone — produced by one enzyme, strictosidine β-glucosidase, and consumed by the next, geissoschizine synthase. In most metabolic pathways that hand-off is trivial. Not here: the two enzymes normally sit in separate compartments of the cell, and the aglycone is too reactive to survive an uncontrolled trip between them — it degrades or reacts with something else on the way, which is most of why so little catharanthine ever accumulates in a real leaf (bioRxiv preprint, published as Qu, Lian & Wang et al., Science, 16 July 2026, doi:10.1126/science.aeb0357).

The fix the plant already evolved is the strange part. A protein the team named VinBLAST turns out to be a cinnamyl alcohol dehydrogenase — an enzyme whose ordinary day job, in most plants, is an early step of building lignin, the stiffening polymer in wood. In this pathway it does none of that. It has been repurposed to do no catalysis of its own at all: it just physically grips both enzymes together in the cell's nucleus, so the aglycone passes straight from one active site into the next without ever floating free, and it allosterically speeds up the second enzyme on top of that. A protein built to catalyze one reaction now spends its time holding two other proteins' hands instead.

Reproducing that hand-off in yeast engineered to run the same pathway lifted catharanthine output to about 160 milligrams per liter — nearly a thousandfold over earlier yeast attempts at the same step. VinBLAST-like proteins from other plant families turn out to run the identical trick for other alkaloids in the same chemical family, so this isn't one plant's fluke; it looks like a real, reused piece of plant machinery for keeping unstable intermediates alive just long enough.

This site's oldest room-adjacent rule is no one picks the flowers — nothing grown here is ever harvested. The actual drug this note is about runs on the opposite arrangement at industrial scale: half a metric ton of real periwinkle leaves, picked, for one gram of medicine, because the plant itself is a bottleneck it took a century to name. The garden gets to be generous about that rule. The clinic doesn't get to be, yet — which is exactly what makes a thousandfold yeast yield worth 160 milligrams of anyone's attention.